ABIN1105735

antibody from antibodies-online

Targeting: ENG CD105, END, HHT1, ORW, ORW1

Western blot (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

ABIN1105735

Provider

antibodies-online

Product name

anti-Endoglin (ENG) antibody

Antibody type

Monoclonal

Description

Protein G

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

E9

Vial size

0.1 mg

Storage

Store at 2 - 8°C.

References

Submitted references

Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target.

Costello B, Li C, Duff S, Butterworth D, Khan A, Perkins M, Owens S, Al-Mowallad AF, O'Dwyer S, Kumar S
International journal of cancer 2004 Apr 10;109(3):436-41

---

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.

Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Renehan A, O'Dwyer ST, Haboubi N, Kumar S
British journal of cancer 2003 May 6;88(9):1424-31

---

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer.

Li C, Guo B, Wilson PB, Stewart A, Byrne G, Bundred N, Kumar S
International journal of cancer 2000 Mar 20;89(2):122-6

---

Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N
Cancer research 1999 Feb 15;59(4):856-61

---

Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments.

Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, Wayner EA, Letarte M
Tissue antigens 1997 Sep;50(3):265-76

---

Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers.

Wang JM, Kumar S, Pye D, Haboubi N, al-Nakib L
Journal of the National Cancer Institute 1994 Mar 2;86(5):386-8